General Information of Drug Off-Target (DOT) (ID: OT5LSKCS)

DOT Name Esterase OVCA2 (OVCA2)
Synonyms EC 3.1.2.-; Ovarian cancer-associated gene 2 protein
Gene Name OVCA2
Related Disease
Lung cancer ( )
Lung carcinoma ( )
Medulloblastoma ( )
Neoplasm ( )
Promyelocytic leukaemia ( )
Acute myelogenous leukaemia ( )
UniProt ID
OVCA2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
3.1.2.-
Pfam ID
PF03959
Sequence
MAAQRPLRVLCLAGFRQSERGFREKTGALRKALRGRAELVCLSGPHPVPDPPGPEGARSD
FGSCPPEEQPRGWWFSEQEADVFSALEEPAVCRGLEESLGMVAQALNRLGPFDGLLGFSQ
GAALAALVCALGQAGDPRFPLPRFILLVSGFCPRGIGFKESILQRPLSLPSLHVFGDTDK
VIPSQESVQLASQFPGAITLTHSGGHFIPAAAPQRQAYLKFLDQFAE
Tissue Specificity Ubiquitously expressed.

Molecular Interaction Atlas (MIA) of This DOT

6 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Lung cancer DISCM4YA Strong Altered Expression [1]
Lung carcinoma DISTR26C Strong Altered Expression [1]
Medulloblastoma DISZD2ZL Strong Biomarker [2]
Neoplasm DISZKGEW Strong Biomarker [3]
Promyelocytic leukaemia DISYGG13 Strong Biomarker [1]
Acute myelogenous leukaemia DISCSPTN moderate Genetic Variation [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
This DOT Affected the Drug Response of 1 Drug(s)
Drug Name Drug ID Highest Status Interaction REF
Acetaldehyde DMJFKG4 Investigative Esterase OVCA2 (OVCA2) increases the response to substance of Acetaldehyde. [10]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Esterase OVCA2 (OVCA2). [5]
------------------------------------------------------------------------------------
4 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Esterase OVCA2 (OVCA2). [6]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Esterase OVCA2 (OVCA2). [7]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Esterase OVCA2 (OVCA2). [8]
Marinol DM70IK5 Approved Marinol decreases the expression of Esterase OVCA2 (OVCA2). [9]
------------------------------------------------------------------------------------

References

1 OVCA2 is downregulated and degraded during retinoid-induced apoptosis.Int J Cancer. 2002 May 10;99(2):185-92. doi: 10.1002/ijc.10334.
2 Mass spectrometric identification of serine hydrolase OVCA2 in the medulloblastoma cell line DAOY.Cancer Lett. 2006 Sep 28;241(2):235-49. doi: 10.1016/j.canlet.2005.10.023. Epub 2005 Dec 20.
3 FSH3 mediated cell death is dependent on NUC1 in Saccharomyces cerevisiae.FEMS Yeast Res. 2019 May 1;19(3):foz017. doi: 10.1093/femsyr/foz017.
4 Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia.Oncotarget. 2017 Jan 31;8(5):7891-7899. doi: 10.18632/oncotarget.13631.
5 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
6 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
7 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
8 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
9 THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry. 2018 Apr 25;8(1):89. doi: 10.1038/s41398-018-0137-3.
10 Genome-Wide CRISPR Screening Identifies the Tumor Suppressor Candidate OVCA2 As a Determinant of Tolerance to Acetaldehyde. Toxicol Sci. 2019 May 1;169(1):235-245. doi: 10.1093/toxsci/kfz037.